Postprandial glucose-lowering effects of fermented red ginseng in subjects with impaired fasting glucose or type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Oh, Mi Ra ^a   Park, Soo Hyun ^a   Kim, Sun Young ^a   Back, Hyang Im ^a   Kim, Min Gul ^a   Jeon, Ji Young ^a   Ha, Ki Chan ^b   Na, Won Taek ^c   Cha, Youn Soo ^d   Park, Byung Hyun ^a   Park, Tae sun ^e   Chae, Soo Wan ^a,e  

^a Chonbuk National University Medical School   (South Korea)

^b Healthcare Claims and Management   (South Korea)

^c Wonkwang Pharmaceutical Co Ltd   (South Korea)

^d Wonkwang Pharmaceutical Co Ltd ^*  (South Korea)

^e Chonbuk National University   (South Korea)

Author keywords

Fermented red ginseng; Impaired fasting glucose; Postprandial glucose; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; FERMENTED RED GINSENG; GINSENG EXTRACT; GLUCOSE; INSULIN; LIPID; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE TOLERANCE TEST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PANAX; PLANT PREPARATIONS; YOUNG ADULT;

EID: 84904084401     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-237     Document Type: Article

References (36)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053.
2. The DECODE study group Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999, 354(9179):617-621. The DECODE study group.
3. Meigs JB, Nathan DM, D'Agostino RB, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002, 25(10):1845-1850.
4. Hong CE, Lyu SY. Anti-inflammatory and anti-oxidative effects of Korean red ginseng extract in human keratinocytes. Immune Netw 2011, 11(1):42-49.
5. Jung JW, Kang HR, Ji GE, Park MS, Song WJ, Kim MH, Kwon JW, Kim TW, Park HW, Cho SH, Min KU. Therapeutic effects of fermented red ginseng in allergic rhinitis: a randomized, double-blind, placebo-controlled study. Allergy Asthma Immunol Res 2011, 3(2):103-110.
6. Lee JS, Choi HS, Kang SW, Chung JH, Park HK, Ban JY, Kwon OY, Hong HP, Ko YG. Therapeutic effect of Korean red ginseng on inflammatory cytokines in rats with focal cerebral ischemia/reperfusion injury. Am J Chin Med 2011, 39(1):83-94.
7. Wee JJ, Park KM, Chung AS. Biological Activities Of Ginseng And Its Application To Human Health. Herbal Medicine: Biomolecular and Clinical Aspects 2011, Boca Raton (FL), Benzie IFF, Wachtel-Galor S, 2.
8. Sun S, Qi LW, Du GJ, Mehendale SR, Wang CZ, Yuan CS. Red notoginseng: higher ginsenoside content and stronger anticancer potential than Asian and American ginseng. Food Chem 2011, 125(4):1299-1305.
9. Taira S, Ikeda R, Yokota N, Osaka I, Sakamoto M, Kato M, Sahashi Y. Mass spectrometric imaging of ginsenosides localization in Panax ginseng root. Am J Chin Med 2010, 38(3):485-493.
10. Wang CZ, Ni M, Sun S, Li XL, He H, Mehendale SR, Yuan CS. Detection of adulteration of notoginseng root extract with other panax species by quantitative HPLC coupled with PCA. J Agri Food Chem 2009, 57(6):2363-2367.
11. Li H, Zhou M, Zhao A, Jia W. Traditional Chinese medicine: balancing the gut ecosystem. Phytother Res 2009, 23(9):1332-1335.
12. Wang HY, Qi LW, Wang CZ, Li P. Bioactivity enhancement of herbal supplements by intestinal microbiota focusing on ginsenosides. Am J Chin Med 2011, 39(6):1103-1115.
13. Bae EA, Park SY, Kim DH. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull 2000, 23(12):1481-1485.
14. Bae EA, Han MJ, Choo MK, Park SY, Kim DH. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol Pharm Bull 2002, 25(1):58-63.
15. Bae EA, Han MJ, Kim EJ, Kim DH. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch Pharm Res 2004, 27(1):61-67.
16. Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, Tono-oka S, Samukawa K, Azuma I. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull 1995, 18(9):1197-1202.
17. Park EK, Choo MK, Kim EJ, Han MJ, Kim DH. Antiallergic activity of ginsenoside Rh2. Biol Pharm Bull 2003, 26(11):1581-1584.
18. Trinh HT, Han SJ, Kim SW, Lee YC, Kim DH. Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng. J Microbiol Biotechnol 2007, 17(7):1127-1133.
19. Yuan HD, Chung SH. Protective effects of fermented ginseng on streptozotocin-induced pancreatic beta-cell damage through inhibition of NF-kappaB. Int J Mol Med 2010, 25(1):53-58.
20. Chakraborty H, Gu H. A mixed model approach for intent-to-treat analysis in longitudinal clinical trials with missing values. [http://www.rti.org/pubs/mr-0009-0904-chakraborty.pdf].
21. Kim HY, Kim K. Regulation of signaling molecules associated with insulin action, insulin secretion and pancreatic beta-cell mass in the hypoglycemic effects of Korean red ginseng in Goto-Kakizaki rats. J Ethnopharmacol 2012, 142(1):53-58.
22. Ha KS, Jo SH, Kang BH, Apostolidis E, Lee MS, Jang HD, Kwon YI. In vitro and in vivo antihyperglycemic effect of 2 amadori rearrangement compounds, arginyl-fructose and arginyl-fructosyl-glucose. J Food Sci 2011, 76(8):H188-193.
23. Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis 2008, 18(1):46-56.
24. Liang ZQ, Srinivasan S, Kim YJ, Kim HB, Wang HT, Yang DC. Lactobacillus kimchicus sp. nov., a beta-glucosidase-producing bacterium isolated from kimchi. Int J Syst Evol Microbiol 2011, 61(Pt 4):894-897.
25. Kim B-G, Choi S-Y, Kim M-R, Suhd HJ, Park HJ. Changes of ginsenosides in Korean red ginseng (Panax ginseng) fermented by Lactobacillus plantarum M1. Process Biochem 2010, 45:1319-1324.
26. Kim BG, Shin KS, Yoon TJ, Yu KW, Ra KS, Kim JM, Kim SY, Suh HJ. Fermentation of Korean red ginseng by Lactobacillus plantarum M-2 and its immunological activities. Appl Biochem Biotechnol 2011, 165(5-6):1107-1119.
27. Luo JZ, Luo L. Ginseng on hyperglycemia: effects and mechanisms. Evid Based Complement Alternat Med : eCAM 2009, 6(4):423-427.
28. Sievenpiper JL, Arnason JT, Leiter LA, Vuksan V. Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: the role of ginsenosides. J Am Coll Nutr 2004, 23(3):248-258.
29. Sievenpiper JL, Sung MK, Di Buono M, Seung-Lee K, Nam KY, Arnason JT, Leiter LA, Vuksan V. Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies. J Am Coll Nutr 2006, 25(2):100-107.
30. Jin H, Seo JH, Uhm YK, Jung CY, Lee SK, Yim SV. Pharmacokinetic comparison of ginsenoside metabolite IH-901 from fermented and non-fermented ginseng in healthy Korean volunteers. J Ethnopharmacol 2012, 139(2):664-667.
31. Kim ST, Kim HB, Lee KH, Choi YR, Kim HJ, Shin IS, Gyoung YS, Joo SS. Steam-dried ginseng berry fermented with Lactobacillus plantarum controls the increase of blood glucose and body weight in type 2 obese diabetic db/db mice. J Agrci Food Chem 2012, 60(21):5438-5445.
32. Onomura M, Tsukada H, Fukuda K, Hosokawa M, Nakamura H, Kodama M, Ohya M, Seino Y. Effects of ginseng radix on sugar absorption in the small intestine. Am J Chin Med 1999, 27(3-4):347-354.
33. Suzuki Y, Ito Y, Konno C, Furuya T. Effects of tissue cultured ginseng on gastric secretion and pepsin activity. Yakugaku zasshi 1991, 111(12):770-774.
34. Waki I, Kyo H, Yasuda M, Kimura M. Effects of a hypoglycemic component of ginseng radix on insulin biosynthesis in normal and diabetic animals. J Pharmacobiodyn 1982, 5(8):547-554.
35. Reeds DN, Patterson BW, Okunade A, Holloszy JO, Polonsky KS, Klein S. Ginseng and ginsenoside Re do not improve beta-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes. Diabetes Care 2011, 34(5):1071-1076.
36. Defronzo RA. Lilly Lecture 1987: The triumvirate: β-cell, muscle, liver: a collusion Responsible for NIDDM. Diabetes Care 1988, 37(6):667-687.